TMO
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc historical holders
total: 23
Dodge & Cox Stock Fund Thermo Fisher Scientific Inc transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Dodge & Cox Stock Fund has been an institutional investor in Thermo Fisher Scientific Inc (TMO) since 2026 Q2. According to 2026 Q2 report, Dodge & Cox Stock Fund holds 2,061,300 shares with a market value of roughly $1.03B representing 0.87% of their equity portfolio. The fund/company first acquired TMO in 2026 Q2, initially purchasing about 2.06M shares.
Does Dodge & Cox Stock Fund still hold TMO?
Yes, Dodge & Cox Stock Fund continues to hold Thermo Fisher Scientific Inc (TMO). According to their 2026 Q2 report, they maintain a position of 2,061,300 shares valued at approximately $1.03B, representing 0.87% of their equity portfolio.
When did Dodge & Cox Stock Fund first invest in TMO?
Dodge & Cox Stock Fund first invested in Thermo Fisher Scientific Inc (TMO) in 2026 Q2 at the reported quarter-end price of $501.36 per share, acquiring 2,061,300 shares in their initial purchase.
What is Dodge & Cox Stock Fund's average cost basis for TMO?
Based on historical transaction data, Dodge & Cox Stock Fund's estimated cost basis for Thermo Fisher Scientific Inc (TMO) is approximately $501.36 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $501.36
TMO transactions history by Dodge & Cox Stock Fund
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.87%
|
2,061,300
|
$501.36
|
$1,033,453,368
|
new
|
+0.87%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.